Serum Fetuin-A levels, insulin resistance and oxidative stress in women with polycystic ovary syndrome

References

• Asuncion M, Calvo RM, San Millan JL, et al. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000;85:2434–8
   PubMed Web of Science ®Google Scholar
• Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997;18:774–800
   PubMed Web of Science ®Google Scholar
• Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance independent of obesity in polycystic ovary syndrome. Diabetes 1989;38:1165–74
   PubMed Web of Science ®Google Scholar
• Arslanian SA, Lewy VD, Danadian K. Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and beta-cell dysfunction and risk of cardiovascular disease. J Clin Endocrinol Metab 2001;86:66–71
   PubMed Web of Science ®Google Scholar
• Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 2010;8:41
   PubMed Web of Science ®Google Scholar
• Stuart D, Nagamani M. Acute augmentation of plasma androstenedione and dehydroepiandrosterone by euglycemic insulin infusion: evidence for a direct effect of insulin on ovarian steroidogenesis. In: Dunaif A, Givens J, Haseltine F, Merriam G, editors. Current issues in endocrinology and metabolism: polycystic ovary syndrome. Cambridge: Blackwell; 1992:279–88
   Google Scholar
• Song AY, Xu M, Bi YF, et al. Serum Fetuin-A Associates with Type 2 Diabetes and Insulin Resistance in Chinese Adults. PLOS One 2011;6:e19228
   Web of Science ®Google Scholar
• Mathews ST, Chellam N, Srinivas PR, et al. Alpha2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor. Mol Cell Endocrinol 2000;164:87–98
   PubMed Web of Science ®Google Scholar
• Mathews ST, Singh GP, Ranalletta M, et al. Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. Diabetes 2002;51:2450–8
   PubMed Web of Science ®Google Scholar
• Halliwell B. Free radicals, antioxidants and human disease: curiosity, cause or consequence? Lancet 1994;344:721–4
   PubMed Web of Science ®Google Scholar
• Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996;19:257–67
   PubMed Web of Science ®Google Scholar
• Fenkci V, Fenkci S, Yilmazer M, Serteser M. Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease. Fertil Steril 2003;80:123–7
   PubMed Web of Science ®Google Scholar
• The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2003;81:19–25
   Google Scholar
• Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961;21:1440–7
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–9
   PubMed Web of Science ®Google Scholar
• Geloneze B, Vasques AC; BRAMS Investigators, et al. HOMA1-IR and HOMA2-IR indexes in identifying insulin resistance and metabolic syndrome: Brazilian Metabolic Syndrome Study (BRAMS). Arq Bras Endocrinol Metabol 2009;53:281–7
   PubMed Web of Science ®Google Scholar
• Okhawa H, Ohishi N. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351–8
   PubMed Web of Science ®Google Scholar
• Winterbourn CC, Hawkings RE, Brian M, Carrel RW. The estimation of red cells superoxide dismutase activity. J Lab Clin Med 1975;85:337–42
   PubMed Web of Science ®Google Scholar
• Enli Y, Oztekin O, Pinarbasili RD. The nitroxide tempol has similar antioxidant effects as physiological levels of 17beta-oestradiol in reversing ovariectomy-induced oxidative stress in mice liver and kidney. Scand J Clin Lab Invest 2009;69:526–34
   PubMed Web of Science ®Google Scholar
• Knight KR, Zhang B, Morrison WA, Stewart AG. Ischaemia-reperfusion injury in mouse skeletal muscle is reduced by N-nitro-L-arginine methyl ester and dexamethasone. Eur J of Pharmacol 1997;332:273–8
   PubMed Web of Science ®Google Scholar
• Ix JH, Chertow GM, Shlipak MG, et al. Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul Study. Circulation 2007;115:2533–9
   PubMed Web of Science ®Google Scholar
• Gulhan I, Bozkaya G, Oztekin D, et al. Serum Fetuin-A levels in women with polycystic ovary syndrome. Arch Gynecol Obstet 2012;286:1473–6
   PubMed Web of Science ®Google Scholar
• Barbieri RL. Insulin stimulates androgen accumulation in incubations of minced porcine theca. Gynecol Obstet Invest 1994;37:265–9
   PubMed Web of Science ®Google Scholar
• Nakazato T, Sagawa M, Yamato K, et al. Myeloperoxidase is a key regulator of oxidative stress-mediated apoptosis in myeloid leukemic cells. Clin Cancer Res 2007;13:5436–45
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zanotti I, Reilly MP, et al. Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo. Circulation 2003;108:661–3
   PubMed Web of Science ®Google Scholar
• Rizzo M, Kotur-Stevuljevic J, Berneis K, et al. Atherogenic dyslipidemia and oxidative stress: a new look. Transl Res 2009;153:217–23
   PubMed Web of Science ®Google Scholar
• Chen HY, Chiu YL, Hsu SP, et al. Association of serum fetuin A with truncal obesity and dyslipidemia in non-diabetic hemodialysis patients. Eur J Endocrinol 2009;160:777–83
   PubMed Web of Science ®Google Scholar